Bank of America Corporation »

Intellia Therapeutics shares owned by Bank of America Corporation

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Bank of America Corporation from 13F filings

Historical chart of Bank of America Corporation investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Bank of America Corporation

Quarter filed Position value Share count Share price at filing
2024-09-30 $15M 716k 20.55
2024-06-30 $15M 648k 22.38
2024-03-31 $17M 626k 27.51
2023-12-31 $12M 380k 30.49
2023-09-30 $13M 414k 31.62
2023-06-30 $17M 411k 40.78
2023-03-31 $50M 1.3M 37.27
2022-12-31 $24M 688k 34.89
2022-06-30 $21M 404k 51.76
2021-12-31 $34M 291k 118.24
2021-06-30 $46M 282k 161.92
2021-03-31 $27M 340k 80.26
2020-12-31 $6.1M 113k 54.42
2020-09-30 $1.2M 59k 19.89
2020-06-30 $525k 25k 21.03
2020-03-31 $437k 36k 12.22
2019-12-31 $437k 30k 14.63
2019-09-30 $407k 30k 13.38
2019-03-31 $1.8M 103k 17.07
2018-12-31 $334k 24k 13.71
2018-06-30 $3.4M 126k 27.36
2018-03-31 $223k 11k 21.08
2017-12-31 $172k 9.0k 19.13
2017-09-30 $659k 26k 24.94
2017-03-31 $245k 18k 13.75
2016-12-31 $42k 3.3k 12.63
2016-09-30 $11k 650 16.60
2016-06-30 $3.0k 132 22.73